[{"Assets_0_Q3_USD":27484000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":5118400000.0,"NetIncomeLoss_1_Q3_USD":1545900000.0,"NetIncomeLoss_3_Q3_USD":4448800000.0,"StockholdersEquity_0_Q3_USD":13995900000.0,"EarningsPerShareBasic_1_Q3_USD":8.4,"EarningsPerShareBasic_3_Q3_USD":23.38,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":184000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":190300000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20191022"}]